 |
Epstein Barr Virus specific cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention and treatment of EBV-post transplant lymphoproliferative disease after hematopoietic stem cell transplant or solid organ transplant |
| USA Market Approval | USA |
| USA Designation Date | 2006-12-27 00:00:00 |
| Sponsor | Center for Cell and Gene Therapy;Feigin Center, Suite 1120;Houston, Texas, 77030 |
